期刊文献+

肥胖对后腹腔镜肾切除治疗上尿路结石导致无功能肾的影响 被引量:1

Effects of obesity on the retroperitoneoscopic nephrectomy for non-functioning kidneys related to upper urinary calculi
下载PDF
导出
摘要 目的分析肥胖对后腹腔镜肾切除治疗上尿路结石导致无功能肾的影响。方法443例上尿路结石导致无功能肾患者,按体质指数分为肥胖组251例,非肥胖组192例。均行后腹腔镜肾切除术。比较两组手术时间,术后平均血红蛋白下降量,住院时间,术中、术后并发症发生率。结果肥胖组手术时间为(124.25±46.52)分钟,非肥胖组为(103.25±40.76)分钟,两组比较差异有统计学意义(P〈0.05);肥胖组住院时间、术后平均血红蛋白下降分别为(6.25±1.43)天和(15.75±14.28)g/L,非肥胖组分别为(5.89±1.27)天和(15.21±14.62)g/L,两组比较差异无统计学意义(P〉0.05);肥胖组术中及术后早期并发症发生率分别为12.5%和6.3%,非肥胖组分别为7.6%和4.0%,两组比较差异无统计学意义(P〉0.05)。结论对于上尿路结石导致的无功能肾的肥胖患者,后腹腔镜肾切除是一种安全可行的手术方式,但手术时间延长。 Objective To investigate the effects of obesity on retroperitoneoscopic nephrectomy for non-functioning kidneys related to upper urinary calculi. Methods A total of 443 patients with non- functioning kidneys related to upper urinary calculi received retroperitoneoscopic nephrectomy, including 251 cases in the obese group and 192 cases in the non-obese group. Results The average operative time of the obese group was longer than the non-obese group [ ( 124.25 ± 46.52) min vs ( 103.25 ± 40.76) min,P 〈0.05 ]. The length of hospital stay and hemoglobin drop of the obese group were similar to those of the non-obese group [ (6.25 ± 1.43)d vs(5.89 ± 1.27)d,P 〉0. 05; ( 15.21 ± 14.62) g/L vs( 15.75± 14.28 ) g/L, P 〉 0.05 ]. There was no significant difference between the groups in the incidence of intraoperative and postoperative complications ( 12.5 % vs 7.6%, P 〉 0.05 ; 6.3 % vs 4.0% , P 〉 0.05 ). Conclusion Retroperitoneoscopic nephrectomy is safe and feasible for obese patients with non-functioning kidneys related to upper urinary calculi, but the operative time may be extended.
出处 《临床外科杂志》 2015年第12期934-936,共3页 Journal of Clinical Surgery
关键词 肥胖 后腹腔镜手术 .肾切除术 上尿路结石 obesity retroperitoneoscopy nephrectomy upper urinary calculi
  • 相关文献

参考文献4

二级参考文献34

  • 1马冠生,李艳平,武阳丰,翟凤英,崔朝辉,胡小琪,栾德春,胡永华,杨晓光.1992至2002年间中国居民超重率和肥胖率的变化[J].中华预防医学杂志,2005,39(5):311-315. 被引量:247
  • 2Emil AT,Jack WM.Smith′s general urology[M] ∥Marshall LS.Urinary stone disease.Berkshire:McGraw-Hill Medivcal,17th edition,2008:246.
  • 3Stamatelou KK,Francis ME,Jones CA,et al.Time trends in reported prevalence of kidney stones in the United States:1976-1994[J].Kidney Int,2003,63(5):1817-1823.
  • 4Mokdad AH,Bowman BA,Ford ES,et al.The continuing epidemics of obesity and diabetes in the United States[J].JAMA,2001,286(10):1195-1200.
  • 5Cho ST,Jung SI,Myung SC,et al.Correlation of metabolic syndrome with urinary stone composition[J].Int J Urol,2013,20(2):208-213.
  • 6Tasca A.Metabolic syndrome and bariatric surgery in stone disease etiology[J].Curr Opin Urol,2011,21(2):129-133.
  • 7Borghi L,Meschi T,Guerra A,et al.Essential arterial hypertension and stone disease[J].Kidney Int,1999,55(6):2397-2406.
  • 8Eisner BH,Porten SP,Bechis SK,et al.Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis[J].J Urol,2010,183(2):576-579.
  • 9McCarron DA,Pingree PA,Rubin RJ,et al.Enhanced parathyroid function in essential hypertension:a homeostatic response to a urinary calcium leak[J].Hypertension,1980,2(2):162-168.
  • 10Kim YJ,Park MS,Kim WT,et al.Hypertension influences recurrent stone formation in nonobese stone formers[J].J Urol,2010,77(5):1069-1063.

共引文献37

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部